Loading...
XJPX7779
Market cap133mUSD
Dec 25, Last price  
164.00JPY
1D
1.23%
1Q
-16.75%
Jan 2017
-90.07%
IPO
-79.75%
Name

Cyberdyne Inc

Chart & Performance

D1W1MN
XJPX:7779 chart
P/E
—
P/S
4.82
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
-0.37%
Rev. gr., 5y
20.57%
Revenues
4.35b
+32.38%
456,375,000631,278,0001,264,902,0001,649,940,0001,728,000,0001,709,000,0001,792,000,0001,875,000,0002,150,000,0003,289,000,0004,354,000,000
Net income
-1.48b
L+395.30%
-688,171,000-915,893,000-718,057,000-789,332,000-673,000,000-632,000,000-152,000,000-59,000,000-492,000,000-298,000,000-1,476,000,000
CFO
-850m
L+494.41%
-539,588,000-779,286,000-258,282,000575,438,000-53,000,000-775,000,000-215,000,000-775,000,000-564,000,000-143,000,000-850,000,000
Earnings
Feb 12, 2025

Profile

CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains equipment and systems for medical and warfare in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high speed light pulse LED array light source that enables real time photoacoustic imaging. It also provides Cybernics Treatment, a treatment that uses HAL to enhance/regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; HAL FIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes' brain-nerve functions; and Neuro HALFIT for enhancement of physical functions. In addition, the company is involved in the provision of rescue supports in disaster sites, and heavy labor supports for factories and plants; and entertainment business. The company was incorporated in 2004 and is headquartered in Tsukuba, Japan.
URL
https://www.cyberdyne.jp/
IPO date
Mar 26, 2014
Employees
257
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
4,354,000
32.38%
3,289,000
52.98%
2,150,000
14.67%
Cost of revenue
6,089,000
4,910,000
3,357,000
Unusual Expense (Income)
NOPBT
(1,735,000)
(1,621,000)
(1,207,000)
NOPBT Margin
Operating Taxes
507,000
446,000
136,000
Tax Rate
NOPAT
(2,242,000)
(2,067,000)
(1,343,000)
Net income
(1,476,000)
395.30%
(298,000)
-39.43%
(492,000)
733.90%
Dividends
Dividend yield
Proceeds from repurchase of equity
(1,188,000)
BB yield
1.95%
Debt
Debt current
244,000
236,000
152,000
Long-term debt
914,000
992,000
930,000
Deferred revenue
96,000
96,000
Other long-term liabilities
5,858,000
4,807,000
3,629,000
Net debt
(19,072,000)
(30,127,000)
(29,857,000)
Cash flow
Cash from operating activities
(850,000)
(143,000)
(564,000)
CAPEX
(216,000)
(509,000)
(1,776,000)
Cash from investing activities
(2,075,000)
2,173,000
(1,788,000)
Cash from financing activities
160,000
14,000
1,248,000
FCF
(13,479,000)
(1,527,000)
(3,065,000)
Balance
Cash
5,155,000
17,308,000
20,828,000
Long term investments
15,075,000
14,047,000
10,111,000
Excess cash
20,012,300
31,190,550
30,831,500
Stockholders' equity
(360,000)
43,374,000
45,152,000
Invested Capital
47,327,000
16,364,450
16,925,500
ROIC
ROCE
EV
Common stock shares outstanding
211,131
214,707
215,135
Price
213.00
-25.00%
284.00
-21.98%
364.00
-43.04%
Market cap
44,970,953
-26.25%
60,976,714
-22.13%
78,309,090
-43.04%
EV
25,623,953
73,811,714
93,054,090
EBITDA
(1,058,000)
(994,000)
(734,000)
EV/EBITDA
Interest
482,000
193,000
4,000
Interest/NOPBT